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Introduction
Glucose is the major energy source of cells. A stable blood glucose is necessary since energy must be supplied to all cells at all times despite intermittent food intake and variable demands, such as the level of physical activity. The major regulatory hormone for intermediary metabolism is insulin, produced and secreted by the β-cells of the islets of Langerhans of the pancreas. Impaired control of blood glucose concentrations by insulin leads to diabetes mellitus. In patients with diabetes, an increased blood glucose concentration (hyperglycaemia) causes an increased thirst, hunger and urine volume, but it is the chronic complications of diabetes that are the major health issues [1] [2] [3] [4] [5] [6] .
Diabetes is reaching epidemic proportions in developed countries 7 . Estimations suggest that diabetes affects about 6% of the population in the USA or 12-15 million people, with up to half being undiagnosed 8, 9 . The prevalence of diabetes increases with age with up to 25-30% of the elderly suffering from the condition and another 10-25% having impaired glucose tolerance 10 . For many patients, diabetes is only diagnosed and aggressively treated when one of characteristic diabetic complications develops. These include cataracts and retinopathy which lead to blindness, impaired kidney function leading to end-stage renal disease, diabetic neuropathy which may lead to tactile allodynia, ulcers or amputations, macrovascular disease such as atherosclerosis and impotence, or heart disease and stroke. In humans, diabetes is associated with long-term cardiovascular damage (especially endothelial dysfunction, fibrosis and cardiomyopathy) with a much higher risk of coronary artery disease, heart failure, myocardial infarction and death
11
.
Diabetes can be induced by selective destruction of the insulin-producing β-cells of the pancreas with a single, rapid injection of streptozotocin (STZ), a glucose moiety with a very reactive nitrosourea group from the mould Streptomyces griseus. This procedure, first introduced in 1963, has since been used in over 7600 PubMed citations, probably making this the second most used animal model of human disease after the spontaneously hypertensive rat (SHR); cardiovascular changes following streptozotocin have been reviewed previously 11 . STZ doses of 50-65 mg/kg lead to hyperglycaemia (20-30 mM) but severe ketosis does not develop even if insulin is not administered. Higher doses (75 mg/kg and above) result in spontaneous ketosis and death within days if insulin is not given.
Most investigations using STZ-diabetic rats have followed the course of the condition for 4-6 weeks, sometimes 8 weeks. However, few studies have extended their measurement period to 24 weeks which is necessary to study the mechanisms of the chronic complications of diabetes such as neuropathy 12, 13 , retinopathy 14 and nephropathy 15 .
Since human diabetics have a markedly increased morbidity and mortality due to cardiovascular disease 1,2 , we emphasise in this report the chronic changes in the cardiovascular system that accompany chronic STZ-induced diabetes in the rat. A comparison with the chronic changes in human diabetes will indicate whether the STZdiabetic rat is an adequate model of the human disease.
Methods
Diabetes was induced in 8 week old male Wistar rats (n=96) using a single rapid injection of streptozotocin (STZ; 65 mg/kg) 16 into the femoral vein. The success rate of inducing diabetes (defined as a blood glucose concentration ≥15 mM and a water intake of >100 19 . At the end of the experiment, the atria were removed and the weight of the ventricles plus septum was recorded.
Conventional microelectrode techniques were applied to the left ventricular papillary muscles to record action potential duration 20 . A stainless steel hook was placed in one end of the papillary muscle fixed at the other end with a small stainless steel pin embedded into a rubber base. The hook was attached to a modified sensor element (SensoNor AE801) connected to an amplifier (World Precision Instruments, TBM-4).
The muscle was slowly stretched to maximum preload over one minute. Contractions were induced by field stimulation (Grass SD-9) via electrodes on either side of the muscle (stimulation frequency 1 Hz, pulse width 0.5 msec; stimulus strength 20% above threshold). After maximum preload was attained, the muscle was allowed to equilibrate Collagen deposition in the heart was visualised following picrosirius red staining 16, 17 and quantified using laser confocal microscopy.
Calibrated Von Frey filaments 21 were used for weekly assessment of the development and maintenance of tactile allodynia in the hindpaws of diabetic relative to non-diabetic rats. Von Frey filaments of varying tensile strength (2 -20g) were applied to the plantar surface of the hindpaw of the rat in ascending order of force, until there was a brisk paw withdrawal response. If the rat failed to withdraw its paw, a response of 20 g was recorded. Higher forces were not used in order to prevent tissue damage to the footpad of the rat.
Every 4 weeks, rats were lightly anaesthetised for assessment of cataract genesis by examination of the rat lens magnified x36 with a slit-lamp biomicroscope. Tropicamide (1% solution) was administered to the eyes to dilate the pupils so as to give a clear view of the lens. Cellufresh ® eye drops (carmellose sodium) were administered periodically to avoid drying of the cornea. Rat lens cataracts were graded using a grading scale: 0, normal clear lens; 1, visible posterior sutures; 2, isolated vacuoles; 3, coalescing peripheral vacuoles; 4, radial streaks and dense central opacities 22 . Rat retinae were isolated at 24 weeks for histochemical evaluation using a diaminobenzidine and glucose oxidase staining procedure for blood vessels.
Data are presented as mean ± SEM. Comparisons of the groups was made using the unpaired Student's t test; p<0.05 was considered significant.
Results
STZ treatment rapidly produced the characteristic signs of diabetes such as increased intake of both water and food, failure to gain weight and increased blood glucose concentrations; these changes were maintained for the 24 weeks of observation (figure 1).
As in humans, untreated diabetes in rats increases mortality as only 52% of STZ-diabetic rats survived 24 weeks of diabetes.
Systolic blood pressure remained normal in STZ-treated rats for the full 24 weeks with mean systolic blood pressure measurements between 100 and 120 mmHg in both control and STZ-diabetic rats. Non-invasive measurement of left ventricular dimensions showed decreased wall thickness and increased internal diameter after 24 weeks only (figure 2).
Systolic function using fractional shortening as an estimate was unchanged. Diastolic function was assessed as the ratio of the initial mitral inflow (maximal E wave velocity) to the second mitral inflow (maximal A wave velocity) 18 . Using this parameter, diastolic function was significantly decreased 24 weeks after STZ treatment (figure 2). Both contractility (dP/dt) and relaxation (-dP/dt) were impaired in the isolated hearts of STZ rats when measured in the perfused Langendorff heart preparation ( figure 3) The resting membrane potential was significantly less depolarised in papillary muscles from STZ-treated rats (control -72.3±0.7 mV; STZ -67.5±0.5 mV; n=6). 
In control rats (n=6), von

Discussion
Our studies on the chronic STZ-diabetic rat show that this model reliably produces many of the signs and symptoms of chronic human diabetes, in particular diastolic cardiac dysfunction, cataracts and neuropathy. An important difference is that rats do not develop atherosclerosis and remain normotensive unlike human diabetics, at least over a 24 week observation period. However, these characteristics of the chronic STZ-diabetic rat allow investigation of hyperglycaemia-induced changes which are independent of the development of atherosclerosis and hypertension.
Diabetes in humans is characterised by a progressive accumulation of complications which markedly increase morbidity and mortality. In both type 1 and type 2 diabetics, cardiovascular disease, especially coronary artery disease due to atherosclerosis, remains the major cause of this increase with a 2-3 fold increase over age-and gender-matched non-diabetic patients [1] [2] [3] . However, there are important contributions from chronic renal, ocular and nerve damage. In a 10-year study of type 2 diabetics, 38% developed microalbuminuria as a symptom of nephropathy 4 while 55% had signs of retinopathy 5 .
Polyneuropathy is also an insidious complication of diabetes affecting about 42% of type 2 diabetics 10 years after diagnosis 6 . Understanding the basis for these complications requires an animal model of chronic diabetes that mimics the changes observed in humans.
Hypertension, obesity, dyslipidaemia, microalbuminuria, endothelial dysfunction, autonomic neuropathy and diabetic cardiomyopathy are amongst the many factors that contribute to the high prevalence of cardiovascular disease in human diabetes 1,2 . STZdiabetic rats slowly developed both diastolic dysfunction and systolic dysfunction as shown in vivo by echocardiography and also in the isolated heart. The diastolic stiffness was also increased in the isolated heart, consistent with an increased collagen deposition 16 . Fibrosis of the myocardium may be associated with inefficient conduction of cardiac pacemaker electrical impulses resulting in arrhythmia. Further, STZ-diabetic rats have a significant increase in duration of action potential in all phases of repolarisation possibly due to a reduction in the transient outward potassium current and the inward calcium current 23 .
The STZ-diabetic rat models diabetic neuropathy due to the similarities of the structural, functional and biochemical abnormalities in the periphery to human diabetic patients 22 .
This study has extended this to the progression of tactile allodynia and painful diabetic neuropathy in chronic diabetes.
Glucose-stressed lens have increased oxidative stress or reduced ability to remove reactive oxygen species or both. Ten-to twenty-fold increases in sorbitol concentration in the lenses due to membrane impermeability and slow conversion to fructose may lead to increased osmotic stress or an erosion of the components required to counter such stress 22 . This study demonstrated that the development of senile cataracts in diabetic lenses was rapid and severe especially considering the lack of cataract development in age-matched control lenses.
Early degeneration of the endothelium by free radical damage, production of AGEs (advanced glycation end-products) and hypersecretion of various basement membrane proteins may affect transport, permeability and integrity of tight junctions and the bloodretinal barrier 24 . This leads to increased capillary leakage as well as microaneurysms which compromises blood and nutrient flow in the retina, causing an ischaemic state. A low oxygen tension stimulates VEGF (vascular endothelial growth factor) synthesis and VEGF receptor expression in an attempt to revascularise the ischaemic retina. Despite this, retinal vascular proliferation is a rare occurrence in animal models of diabetes 25 , as observed in this study. However, we observed the formation of numerous microaneurysms and ghost vessels as well as loop-like vessels, all of which are indicative of progression towards proliferative retinopathy. This suggests that retinopathy does occur and vascular proliferation would be observed if the measurement period could be extended.
The incidence and severity of chronic complications in diabetic humans necessitates therapeutic interventions. The chronic STZ-diabetic rat has been used for testing the effects of novel pharmacological agents, for example troglitazone in neuropathy 12 and ramipril or valsartan in nephropathy 15 . These chronic studies should provide useful options for testing therapeutic approaches to ameliorate chronic diabetic complications in humans.
In conclusion, these results indicate that the chronic STZ-diabetic rat mimics many but not all of the chronic complications observed in the diabetic human. 
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